APOE and Alzheimer disease: Notably, cPLA2 reduction ameliorates cognitive deficits in an AD mouse model and resolves chronic neuroinflammation from low docosahexaenoic acid DHA diets in apoE ε4‐TR mice and increases brain DHA and eicosapentaenoic acid (EPA) levels.76